Richard Vosser
Stock Analyst at J.P. Morgan
(3.31)
# 2,419
Out of 4,587 analysts
1219
Total ratings
49.6%
Success rate
2.1%
Average return
Main Sectors:
Stocks Rated by Richard Vosser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: AZN AstraZeneca PLC | Maintained: Buy | 16,000p | 12,824p | +24.77% | 35 | Jul 27, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Buy | €295.00 | €228.70 | +28.99% | 75 | Jul 24, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €260.00 | €173.70 | +49.68% | 29 | Jul 24, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €95.00 | €75.46 | +25.89% | 165 | Jul 24, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Buy | CHF 135.00 | CHF 127.88 | +5.57% | 119 | Jul 22, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Buy | €50.00 | €48.13 | +3.89% | 145 | Jul 17, 2026 | |
| EPA: IPN Ipsen S.A. | Maintained: Hold | n/a | $164.40 | - | 16 | Jun 29, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 250.00 | kr 335.80 | -25.55% | 155 | Jun 29, 2026 | |
| ETR: MRK Merck KGaA | Maintained: Buy | €150.00 | €144.10 | +4.09% | 145 | Jun 1, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 325.00 | CHF 355.20 | -8.50% | 191 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €950.00 | €752.80 | +26.20% | 3 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1,958.00 | - | 7 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $925 → $1,100 | $882.56 | +24.64% | 2 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €230.00 → €300.00 | €249.17 | +20.40% | 19 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 3.50 → CHF 3.00 | CHF 3.24 | -7.41% | 15 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $51.58 | - | 21 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $158.83 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.5 → $4 | $3.93 | +1.78% | 8 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €250.00 → €260.00 | €180.80 | n/a | 17 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 645.00 → CHF 650.00 | CHF 579.60 | n/a | 15 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €3.00 → €3.50 | €0.95 | n/a | 6 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $54 → $39 | $13.67 | n/a | 7 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €43.65 | €51.35 | n/a | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 3,000p | 1,602p | n/a | 7 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $176 | $43.22 | n/a | 1 | Mar 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $54.99 | n/a | 3 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $142 | $142.88 | n/a | 1 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $205 → $200 | $27.72 | n/a | 2 | Mar 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €185.00 | €24.16 | n/a | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | kr 1,150 | kr 1,892 | n/a | 1 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $28.52 | n/a | 1 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $44.85 | n/a | 1 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 | $8.15 | n/a | 1 | Jan 4, 2017 |
AstraZeneca PLC
Jul 27, 2026
Maintained: Buy
Price Target: 16,000p
Current: 12,824p
Upside: +24.77%
Sartorius Aktiengesellschaft
Jul 24, 2026
Maintained: Buy
Price Target: €295.00
Current: €228.70
Upside: +28.99%
Sartorius Stedim Biotech S.A.
Jul 24, 2026
Maintained: Buy
Price Target: €260.00
Current: €173.70
Upside: +49.68%
Sanofi
Jul 24, 2026
Maintained: Hold
Price Target: €95.00
Current: €75.46
Upside: +25.89%
Novartis AG
Jul 22, 2026
Maintained: Buy
Price Target: CHF 135.00
Current: CHF 127.88
Upside: +5.57%
Bayer Aktiengesellschaft
Jul 17, 2026
Maintained: Buy
Price Target: €50.00
Current: €48.13
Upside: +3.89%
Ipsen S.A.
Jun 29, 2026
Maintained: Hold
Price Target: n/a
Current: $164.40
Upside: -
Novo Nordisk A/S
Jun 29, 2026
Maintained: Hold
Price Target: kr 250.00
Current: kr 335.80
Upside: -25.55%
Merck KGaA
Jun 1, 2026
Maintained: Buy
Price Target: €150.00
Current: €144.10
Upside: +4.09%
Roche Holding AG
May 1, 2026
Maintained: Hold
Price Target: CHF 325.00
Current: CHF 355.20
Upside: -8.50%
Mar 5, 2026
Maintained: Buy
Price Target: €950.00
Current: €752.80
Upside: +26.20%
Dec 23, 2025
Maintained: Sell
Price Target: n/a
Current: $1,958.00
Upside: -
Dec 8, 2025
Maintained: Buy
Price Target: $925 → $1,100
Current: $882.56
Upside: +24.64%
Dec 8, 2025
Maintained: Buy
Price Target: €230.00 → €300.00
Current: €249.17
Upside: +20.40%
Dec 8, 2025
Maintained: Hold
Price Target: CHF 3.50 → CHF 3.00
Current: CHF 3.24
Upside: -7.41%
Nov 24, 2025
Maintained: Buy
Price Target: n/a
Current: $51.58
Upside: -
Nov 20, 2025
Maintained: Hold
Price Target: n/a
Current: $158.83
Upside: -
Sep 3, 2025
Maintained: Hold
Price Target: $4.5 → $4
Current: $3.93
Upside: +1.78%
Jul 22, 2025
Maintained: Buy
Price Target: €250.00 → €260.00
Current: €180.80
Upside: n/a
Dec 3, 2024
Maintained: Buy
Price Target: CHF 645.00 → CHF 650.00
Current: CHF 579.60
Upside: n/a
Dec 3, 2024
Maintained: Hold
Price Target: €3.00 → €3.50
Current: €0.95
Upside: n/a
Dec 5, 2023
Maintained: Hold
Price Target: $54 → $39
Current: $13.67
Upside: n/a
Jan 3, 2023
Upgraded: Buy
Price Target: €43.65
Current: €51.35
Upside: n/a
Sep 27, 2021
Maintained: Buy
Price Target: 3,000p
Current: 1,602p
Upside: n/a
Mar 18, 2021
Maintained: Buy
Price Target: $176
Current: $43.22
Upside: n/a
Dec 21, 2020
Maintained: Buy
Price Target: n/a
Current: $54.99
Upside: n/a
Jul 28, 2020
Maintained: Buy
Price Target: $142
Current: $142.88
Upside: n/a
Mar 2, 2020
Maintained: Hold
Price Target: $205 → $200
Current: $27.72
Upside: n/a
Jan 6, 2020
Downgraded: Hold
Price Target: €185.00
Current: €24.16
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: kr 1,150
Current: kr 1,892
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $28.52
Upside: n/a
Apr 11, 2017
Upgraded: Hold
Price Target: n/a
Current: $44.85
Upside: n/a
Jan 4, 2017
Upgraded: Buy
Price Target: $22
Current: $8.15
Upside: n/a